CAMELLIA: Anti-CD47 Antibody Therapy in Haematological Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Gilead Sciences
Related studies linked through entity extraction aliases.
Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks in Participants With Chronic HCV
- Status
- COMPLETED
- Phase
- PHASE3
HIV Drug Switch Followed by HCV Therapy in HIV-HCV Co-Infection
- Status
- COMPLETED
- Phase
- PHASE3
Immediate Initiation of Antiretroviral Therapy During "Hyperacute" HIV Infection
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE4
Study in Healthy Volunteers to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GS-9674 (Cilofexor), and the Effect of Food on GS-9674 Pharmacokinetics and Pharmacodynamics
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Efficacy of Switching to a FDC of B/F/TAF From E/C/F/TAF, E/C/F/TDF, or ATV+RTV+FTC/TDF in Virologically Suppressed HIV-1 Infected Women
- Status
- COMPLETED
- Phase
- PHASE3
Safety and Efficacy of SOF/VEL/VOX FDC for 8 Weeks and SOF/VEL for 12 Weeks in Adults Chronic Genotype 3 HCV Infection and Cirrhosis
- Status
- COMPLETED
- Phase
- PHASE3
Safety and Efficacy of SOF/VEL/VOX FDC for 12 Weeks and SOF/VEL for 12 Weeks in DAA-Experienced Adults With Chronic HCV Infection Who Have Not Received an NS5A Inhibitor
- Status
- COMPLETED
- Phase
- PHASE3
Therapy With Ledipasvir/Sofosbuvir in Patients With Genotype 1 HCV Infection Receiving Opiate Substitution Therapy
- Status
- UNKNOWN
- Phase
- PHASE4
Study to Evaluate Safety and Pharmacokinetics of GS-4059 (Tirabrutinib) in Healthy Volunteers and Participants With Rheumatoid Arthritis (RA)
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Research Platform Into Molecular Testing, Treatment and Outcome of (Non-)Small Cell Lung Carcinoma Patients
- Status
- RECRUITING
- Phase
- N/A
A Quality Improvement Approach to the Management of Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- NA
Switching From a Tenofovir Disoproxil Fumarate (TDF) Containing Regimen to Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Alafenamide (E/C/F/TAF) Fixed-Dose Combination (FDC) in Virologically-Suppressed, HIV-1 Infected Adults Aged ≥ 60 Years
- Status
- COMPLETED
- Phase
- PHASE3
Study to Evaluate Switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Fixed Dose Combination (FDC) in Virologically-Suppressed HIV-1 Infected Adults Harboring the Archived Isolated NRTI Resistance Mutation M184V/M184I
- Status
- COMPLETED
- Phase
- PHASE3
Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination in Adults With Chronic HCV and HBV Coinfection
- Status
- COMPLETED
- Phase
- PHASE3
Study to Evaluate the Effects of Two Doses of Seladelpar (MBX-8025) in Subjects With Primary Biliary Cirrhosis (PBC)
- Status
- TERMINATED
- Phase
- PHASE2
Study to Evaluate the Safety and Efficacy of Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir + Emtricitabine/Tenofovir Alafenamide in Human Immunodeficiency Virus (HIV-1) Infected, Antiretroviral Treatment-Naive Adults
- Status
- COMPLETED
- Phase
- PHASE3
Study to Evaluate the Safety and Efficacy of Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Abacavir/Dolutegravir/Lamivudine in Human Immunodeficiency Virus-1 (HIV-1) Infected, Antiretroviral Treatment-Naive Adults
- Status
- COMPLETED
- Phase
- PHASE3
Safety and Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir and Sofosbuvir/Velpatasvir in Adults With Chronic HCV Infection Who Have Not Previously Received Treatment With Direct-Acting Antiviral Therapy
- Status
- COMPLETED
- Phase
- PHASE3
Safety and Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir in Adults With Chronic HCV Infection Who Have Previously Received Treatment With Direct-Acting Antiviral Therapy
- Status
- COMPLETED
- Phase
- PHASE3